Back to BCAX
T. Rowe Price Investment Management, Inc. → BCAX
T. Rowe Price Investment Management, Inc. BCAX Position History
Bicara Therapeutics Inc. • Healthcare
Quarters held
5
Latest value
$52.2M
Q3 2026
Peak value
$188.2M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $2.8M |
| Q4 2025 | $54.5M |
| Q1 2026 | $131.4M |
| Q2 2026 | $188.2M |
| Q3 2026 | $52.2M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $52.2M | 2.80M | — | — |
| Q2 2026 | $188.2M | 6.34M | — | — |
| Q1 2026 | $131.4M | 6.61M | — | — |
| Q4 2025 | $54.5M | 3.24M | — | — |
| Q4 2025 | $2.8M | 165.2K | — | — |
Other funds holding BCAX
$215.4M
$166.4M
$155.9M
$144.3M
$121.7M
$117.1M
$115.4M